Mark Lillie

Mark Lillie has extensive work experience in the pharmaceutical industry. Mark started their career at sanofi-aventis in 2001 as a Group Product Manager, where they were responsible for managing a team and overseeing marketing activities for multiple products. Mark then joined Pfizer Inc in 2004 and held roles as a Team Leader and later as a Marketing Director. In these positions, they played a key role in strategic planning and implementation of marketing initiatives. Since 2018, Mark has been working at Pfizer Pharmaceuticals as a Commercial Director for the Rare Disease Vyndaqel, where their focus is on launch readiness and market excellence across EU markets. Mark'sresponsibilities also include identifying and communicating customer insights and best practices to shape the global brand strategy.

Mark Lillie attended the University of Stirling from 1988 to 1992, where they obtained their BA Hons degree in Marketing.